Associate Director, Nonclinical Pharmacology

About the role

Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Our mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. We are advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.

Benefits

• Market competitive compensation and benefits package, including base salary, performance bonus, equity grant opportunities, health (medical, dental, vision, etc.), wellness, and retirement benefits.
• Flexible time off policy, and a holiday policy that includes one-week company-wide shutdowns each year.
• Hybrid and remote working environment with frequent in-person meetings to address complex problems and build relationships.
• Opportunity to be a part of building and growing an exciting new company with the potential to change the trajectory of life-altering skin diseases and improve patients’ lives.